Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SNY · against 1,336 other Healthcare companies
Ranked #155 of 1,337 · scores higher than 88% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including SNY · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | SNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 4.1% | 1.5% | 72% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 12.0% | 4.2% | 85% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 7.3% | -1.0% | 89% | 20% | |
| Book yieldHigher is better · 1,306 reported | 74.5% | 37.9% | 79% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 155 | 133.4B JPY (≈$907M) | 88 | 53 | |
| 155 | 3.4B EUR (≈$3.7B) | 88 | 64 | |
| 155 | 142.5B INR (≈$1.7B) | 88 | 71 | |
| 155 | 133M USD | 88 | 51 | |
| 155 | 108.6B USD | 88 | 66 | |
| 169 | 6.3B CNY (≈$881M) | 87 | 44 | |
| 169 | 200.2B KRW (≈$144M) | 87 | 62 | |
| 169 | 326.5B KRW (≈$235M) | 87 | 52 | |
| 169 | 1.03T JPY (≈$7.0B) | 87 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score